D-penicillamine elastosis perforans serpiginosa: Description of two cases and review of the literature

Dermatology Online Journal

Volumn 17, Issue 4, 2011, Pages

  Atzori, Laura ^a   Pinna, Anna Luisa ^a   Pau, Monica ^a   Aste, Nicola ^a  

^a Dermatology Departments of Cagliari University   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CERULOPLASMIN; CORTICOSTEROID; LIQUID NITROGEN; PENICILLAMINE; ZINC DERIVATIVE;

ADULT; ARTICLE; BASOPHIL; CASE REPORT; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELASTIC FIBER; ELASTOSIS; ELASTOSIS PERFORANS SERPIGINOSA; GRANULOMA ANNULARE; HEPATOMEGALY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LIVER FUNCTION TEST; LONG TERM CARE; MALE; PRESCRIPTION; PROTEIN BLOOD LEVEL; SCAR FORMATION; SKIN BIOPSY; TINEA CORPORIS; TREATMENT DURATION; WILSON DISEASE;

EID: 79960718234     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mehta RK, Burrows NP, Payne CM, Mendelsohn SS, Pope FM, Rytina E. Elastosis perforans serpiginosa and associated disorders. Clin Exp Dermatol 2001; 26:521-4.
2. Vearrier D, Buka RL, Roberts B, Cunningham BB, Eichenfield LF, Friedlander SF. What is standard of care in the evaluation of elastosis perforans serpiginosa? A survey of pediatric dermatologists. Pediatr Dermatol 2006; 23:219-24.
3. Langeveld-Wildschut EG, Toonstra J, van Vloten WA, Beemer FA. Familial elastosis perforans serpiginosa. Arch Dermatol 1993;129: 205-7.
4. Pass F, Goldfischer S, Sternlieb I, Scheinberg IH. Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease. Arch Dermatol 1973;108:713-5.
5. Iozumi K, Nakagawa H, Tamaki K. Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses. J Dermatol 1997l;24:458-65.
6. Deguti MM, Mucenic M, Cancado EL, Tietge UJ. Elastosis perforans serpiginosa secondary to D-penicillamine treatment in a Wilson's disease patient. Am J Gastroenterol 2002; 97: 2153-4.
7. Devillière M, Ingen-Housz-Oro S, Weber N, Cordoliani F, Vignon-Pennamen MD, Manciet JR, Sigal-Grinberg M. [D-penicillamin-induced elastosis perforans serpiginosa] Ann Dermatol Venereol 2007; 134:799-800.
8. Sahn EE, Maize JC, Garen PD, Mullins SC, Silver RM. D-penicillamine-induced elastosis perforans serpiginosa in a child with juvenile rheumatoid arthritis. Report of a case and review of the literature. J Am Acad Dermatol. 1989;20:979-88.
9. Price RG, Prentice RS. Penicillamine-induced elastosis perforans serpiginosa. Tip of the iceberg? Am J Dermatopathol. 1986;8:314-20.
10. Reymond JL, Stoebner P, Zambelli P, Beani JC, Amblard P. Penicillamine induced elastosis perforans serpiginosa: an ultrastructural study of two cases. J Cutan Pathol 1982; 9: 352-7.
11. Bardach H, Gebhart W, Niebauer G. "Lumpy-bumpy" elastic fibers in the skin and lungs of a patient with a penicillamine-induced elastosis perforans serpiginosa. J Cutan Pathol 1979;6:243-52.
12. Matsuda I, Pearson T, Holtzman NA. Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood. Pediatr Re. 1974;8:821-4.
13. Nimni ME. Penicillamine and collagen metabolism. Scand J Rheumatol Suppl 1979;28:71-8.
14. Uitto J, Helin P, Rasmussen O, Lorenzen I. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine. Ann Clin Res 1970;2:228-34.
15. Mehregan AH. Elastosis perforans serpiginosa: a review of the literature and report of 11 cases. Arch Dermatol 1968; 97: 381-93.
16. Fujimoto N, Akagi A, Tajima S, Ishibashi A, Nomura K, Matsushita A, Nagai Y, Shishiba K. Expression of the 67-kDa elastin receptor in perforating skin disorders. Br J Dermatol 2002;146:74-9.
17. Schneider W, Bock H. [Elastoma perforans serpigiosum]. Hautarzt 1976; 27:117-21.
18. Meyrick Thomas RH, Kirby JD. Elastosis perforans serpiginosa and pseudoxanthoma elasticum-like skin change due to D-penicillamine. Clin Exp Dermatol 1985; 10:386-91.
19. Hashimoto K, McEnvoy B, Blecher R. Ultrastructure of penicillamine induced skin lesions. J Am Acad Dermatol 1981; 4: 300-15.
20. Kirsch N, Hukill PB. Elastosis perforans serpiginosa induced by penicillamine. Arch Dermatol. 1977;113:630-5.
21. Gebhart W, Bardach H. The "lumpy-bumpy" elastic fibers. A marker for long-term administration of penicillamine. Am J Dermatopathol. 1981 Spring;3(1):33-9.
22. Rosen LB, Muellenhoff M, Tran TT, Muhart M. Elastosis perforans serpiginosa secondary to D-penicillamine therapy with coexisting cutis laxa. Cutis. 2005;76:49-53.
23. Amichai B, Rotem A, Metzker A. D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease. Isr J Med Sci 1994;30:667-9.
24. Hill VA, Seymour CA, Mortimer PS. Penicillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease. Br J Dermatol 2000; 142: 506-11.
25. Rath N, Bhardwaj A, Kar HK, Sharma PK, Bharadwaj M, Bharija SC. Penicillamine induced pseudoxanthoma elasticum with elastosis perforans serpiginosa. Indian J Dermatol Venereol Leprol 2005;71:182-5.
26. Bécuwe C, Dalle S, Ronger-Savlé S, Skowron F, Balme B, Kanitakis J, Thomas L. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine. Dermatology 2005;210:60-3.
27. Barnadas MA, Curell R, Pujol R, de Moragas JM, Alomar A. Elastosis perforans serpiginosa in a patient with pseudoxanthoma elasticum. Actas Dermosifiliogr 2006;97:451-5.
28. Takahashi H, Nagao S, Iijima S, Haruyama H. A case of elastosis perforans serpiginosa associated with Pseudoxanthoma elasticum. Nippon Hifuka Gakkai Zasshi 1982;92:91-101.
29. Lund HZ, Gilbert CF. Perforating pseudoxanthoma elasticum. Its distinction from elastosis perforans serpiginosa. Arch Pathol Lab Med 1976; 100: 544-6.
30. Lewis BK, Chern PL, Stone MS. Penicillamine-induced elastosis of the mucosal lip. J Am Acad Dermatol 2009;60:700-3.
31. Tovaru S, Parlatescu I, Dumitriu AS, Bucur A, Kaplan I. Oral complications associated with d-penicillamine treatment for Wilson disease: a clinicopathologic report. J Periodontol 2010; 81: 1231-6.